BioCentury
ARTICLE | Emerging Company Profile

Cellino: Automating complex production, differentiation of iPS cells into cell therapies

Via $80M A round for manufacturing play, Bayer deepens its reach into next-gen cell therapy technologies

January 26, 2022 2:18 AM UTC


Access this Article